Delivery Order HHSN272201300004I-HHSN27200001
Award Date 5/1/13
Potential Completion Date 4/30/20
Potential Value $1.7M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
New Orleans, LA 70112, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
6
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a task order awarded under an Indefinite Delivery Contract (IDC) by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Louisiana at Lafayette, operating as the Office of Research. The task order, valued at $799,674.00, is for the maintenance of a nonhuman primate colony in an ABSL2/3 facility to support the Simian Vaccine Evaluation Units (SVEU) program. The SVEU program focuses on the preclinical evaluation of HIV/AIDS vaccines and prevention...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to The Administrators of Tulane Educational Fund, doing business as Tulane University, a private university in New Orleans, Louisiana. The contract is for Simian Vaccine Evaluation Units, with a ceiling value of $1,833,205.37 and a performance period through April 30, 2022. The contract is a delivery order issued under the...
- This is a $294,760.24 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc. under the Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract. The contract is for SIMIAN VACCINE EVALUATION UNITS and does not have a set-aside designation. Bioqual is a prime contractor that provides animal research services, including housing and caring for nonhuman primates,...
- This is a cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL) for the "Simian Vaccine Evaluation Units" program. The contract has a ceiling value of $15,116,116.33 and a period of performance through September 9, 2023. This is a delivery order issued under a larger Simian Vaccine Evaluation Units 2013-2020 IDIQ (Indefinite...
- This is a federal contract award to Bioqual, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, for "SIMIAN VACCINE EVALUATION UNITS". The contract has a ceiling value of $4,398,713.69 and an ultimate completion date of September 13, 2024. The contract is a Delivery Order under the Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle, which allows for task orders related to primate vaccine...
- This is a task order awarded to Bioqual, Inc., a for-profit biomedical research services company, under the Simian Vaccine Evaluation Units (SVEUS) indefinite delivery contract with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The task order, valued at $2,303,697.53, is for administrative and technical support for the SVEUS program, which focuses on developing and refining animal models for evaluating countermeasures...
- This is a $608,420.77 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc. for "SIMIAN VACCINE EVALUATION UNITS". The contract is a task order issued under the Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. Bioqual, a for-profit organization, provides animal research support services including housing, care, and testing for...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL) for the "Simian Vaccine Evaluation Units" program. The $3,605,430.51 cost-plus-fixed-fee contract does not have a set-aside designation and runs through September 9, 2023. It is part of a larger Simian Vaccine Evaluation Units 2013-2020...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization, to provide services for the Simian Vaccine Evaluation Units (SVEU) program. The $2,045,093.69 cost-plus-fixed-fee contract is a delivery order under a master Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract vehicle...
- This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) to the prime contractor Bioqual, Inc. under the Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The $1,013,933.17 award supports the Simian Vaccine Evaluation Units program, which involves conducting animal studies, providing laboratory analysis services, and...
- Simian Vaccine Evaluation Units 2013-2020Master IDIQ
- HHSN272201300004IIndefinite Delivery Contract
- HHSN272201300004I-HHSN27200001Delivery Order
SIMIAN VACCINE EVALUATION UNITS
Posted 5/1/13
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
SIMIAN VACCINE EVALUATION UNITS | RFP-NIAID-DAIDS-NIHAI2012138 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 5/21/12, 3:03 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00013 | Close Out | ($33k) | 6/22/22 | |
| P00012 | Funding Only Action | ($2k) | 12/21/20 | |
| P00011 | Funding Only Action | ($292) | 8/28/20 | |
| P00010 | Funding Only Action | ($30k) | 2/27/19 | |
| P00009 | Exercise an Option | $272.1k | 2/13/19 |